Highly recommended unconjugated mixture of MAbs and PAbs directed against human Type I IFN receptor and several Type I IFNs. Effectively neutralizes biological activity of human IFN-Alpha, IFN-Beta, IFN-Omega, IFN-Kappa, and IFN-Epsilon.
Product Info
| Specificity | Blocks biological activity of human Type I interferons (alpha, beta, omega, kappa, epsilon)
|
|---|---|
| Tested Application |
|
Improves neutralization of multiple Type I IFNs often found in complex samples by employing a broadly neutralizing custom antibody cocktail.
Documentation
Certificate of Analysis (CoA) and Safety Data Sheet (SDS)
39000-1 CoA
39000-1 Certificate of Analysis
39000 SDS
39000 Safety Data Sheet
| Formulation | Supplied frozen in phosphate-buffered saline (PBS) |
|---|---|
| Purification | A combination of Protein G affinity chromatography and other conventional chromatographical methods. Endotoxin level < 1 EU/μg |
| Bioactivity | Encephalomyocarditis Virus (EMCV) was used to challenge A549 cells which were incubated with a constant concentration of the antibody mixture and the titrated interferon. |
| Storage | For retention of full activity store at -70°C or below and avoid repeated freeze/thaw cycles |
| Synonyms | Type I interferon, Type I IFN, Neutralizing, Neutralization, Type I Interferon Receptor, Antibody Cocktail |